Medicus Pharma Ltd. (MDCXW) Research & Development (2024 - 2026)
Medicus Pharma's (MDCXW) quarterly Research & Development came in at -$996039.0 in Q4 2025, down 111.43% on a QoQ basis from $8.7 million in Q3 2025.
Medicus Pharma Ltd. (MDCXW) Research & Development (2024 - 2026) Analysis & Trends
Medicus Pharma (MDCXW) has 2 years of Research & Development data on file, last reported at -$996039.0 in Q4 2025.
- Quarterly Research & Development changed N/A year-over-year to -$996039.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.2 million (up 598.59% YoY) and the FY2025 annual result came in at $7.7 million, changed N/A from the prior year.
- Research & Development slipped to -$996039.0 in Q4 2025, from $8.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $8.7 million in Q3 2025 to a low of -$996039.0 in Q4 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.91 Mn |
| Dec 31, 2025 | -996,039.00 |
| Sep 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 321,377.00 |